Spiro [2.4] heptane Derivatives of fluorinated bridged; Pharmaceutical Composition and use as ALX receptor agonists in the treatment of inflammatory diseases, Allergic. Cardiovascular, among others.
The present invention relates to fluorinated bridged spiro[2.4]heptane derivatives of formula (I), wherein n and R1 are as defined in the description, their preparation and their use as pharmaceutically active compounds.Compuestos derivados de espiro[2.4]heptano puenteados fluorados, agonistas del receptor de ALX; composición farmacéutica que los comprende; y su uso en el tratamiento de enfermedades inflamatorias, respiratorias, alérgicas, virales, cardiovasculares, neurológicas e inmunes.